Nephros Inc has filed an 8-K report with the SEC on March 27, 2026, detailing a Regulation FD disclosure and accompanying financial statements. The filing, which is accessible through the SEC's EDGAR database, includes information under Item 7.01 regarding the Regulation FD disclosure and Item 9.01 concerning financial statements and exhibits. The report is part of the company's ongoing compliance with SEC regulations, ensuring transparency in its financial reporting. The filing does not indicate any significant changes in the company's financial position or operations that would impact stock performance. The company continues to operate within its established business framework, with no immediate concerns raised in this disclosure. Investors are encouraged to review the full filing for detailed financial information and any potential implications for future performance. The filing can be accessed at the SEC's website for further insights into Nephros Inc's current standing and operational updates.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.